ImpediMed Limited (IPDQF)
USD 0.03
(0.0%)
USD 0.03
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | -23.48 Million AUD | 46.93% |
| 2023 | -44.26 Million AUD | -9.13% |
| 2022 | -40.56 Million AUD | -111.17% |
| 2021 | -19.2 Million AUD | -2.21% |
| 2020 | -18.79 Million AUD | -65.86% |
| 2019 | -11.33 Million AUD | 63.85% |
| 2018 | -31.34 Million AUD | 42.89% |
| 2017 | -54.88 Million AUD | 33.27% |
| 2016 | -82.25 Million AUD | -152.45% |
| 2015 | -32.58 Million AUD | -201.35% |
| 2014 | -10.81 Million AUD | -47.79% |
| 2013 | -7.31 Million AUD | 49.7% |
| 2012 | -14.54 Million AUD | 18.88% |
| 2011 | -17.93 Million AUD | 4.57% |
| 2010 | -18.78 Million AUD | -183.24% |
| 2009 | -6.63 Million AUD | 21.23% |
| 2008 | -8.42 Million AUD | 45.64% |
| 2007 | -15.49 Million AUD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -35.63 Million AUD | 0.86% |
| 2024 Q4 | -23.48 Million AUD | 4.64% |
| 2024 FY | -23.48 Million AUD | 46.93% |
| 2024 Q1 | -35.94 Million AUD | 11.39% |
| 2024 Q3 | -24.63 Million AUD | 30.87% |
| 2023 Q1 | -25.08 Million AUD | 38.16% |
| 2023 FY | -44.26 Million AUD | -9.13% |
| 2023 Q2 | -24.87 Million AUD | 0.85% |
| 2023 Q4 | -40.56 Million AUD | 8.98% |
| 2023 Q3 | -44.56 Million AUD | -79.18% |
| 2022 Q1 | -50.78 Million AUD | -164.43% |
| 2022 FY | -40.56 Million AUD | -111.17% |
| 2022 Q2 | -50.48 Million AUD | 0.6% |
| 2022 Q4 | -40.56 Million AUD | 0.42% |
| 2022 Q3 | -40.73 Million AUD | 19.32% |
| 2021 Q3 | -19.52 Million AUD | -6.25% |
| 2021 FY | -19.2 Million AUD | -2.21% |
| 2021 Q2 | -18.37 Million AUD | 1.77% |
| 2021 Q1 | -18.7 Million AUD | 0.46% |
| 2021 Q4 | -19.2 Million AUD | 1.61% |
| 2020 Q3 | -19.15 Million AUD | -57.82% |
| 2020 FY | -18.79 Million AUD | -65.86% |
| 2020 Q4 | -18.79 Million AUD | 1.9% |
| 2020 Q1 | -12.43 Million AUD | -9.76% |
| 2020 Q2 | -12.13 Million AUD | 2.4% |
| 2019 Q2 | -22.63 Million AUD | 0.0% |
| 2019 Q4 | -11.33 Million AUD | 0.0% |
| 2019 FY | -11.33 Million AUD | 63.85% |
| 2019 Q1 | -22.63 Million AUD | 27.78% |
| 2019 Q3 | -11.33 Million AUD | 49.95% |
| 2018 Q1 | -42.4 Million AUD | 22.74% |
| 2018 FY | -31.34 Million AUD | 42.89% |
| 2018 Q3 | -31.34 Million AUD | 26.08% |
| 2018 Q2 | -42.4 Million AUD | 0.0% |
| 2018 Q4 | -31.34 Million AUD | 0.0% |
| 2017 Q3 | -54.88 Million AUD | 25.06% |
| 2017 Q2 | -73.23 Million AUD | 0.0% |
| 2017 FY | -54.88 Million AUD | 33.27% |
| 2017 Q1 | -73.23 Million AUD | 10.96% |
| 2017 Q4 | -54.88 Million AUD | 0.0% |
| 2016 FY | -82.25 Million AUD | -152.45% |
| 2016 Q4 | -82.25 Million AUD | 0.0% |
| 2016 Q3 | -82.25 Million AUD | -227.03% |
| 2016 Q2 | -25.15 Million AUD | 0.0% |
| 2016 Q1 | -25.15 Million AUD | 22.8% |
| 2015 FY | -32.58 Million AUD | -201.35% |
| 2015 Q4 | -32.58 Million AUD | 0.0% |
| 2015 Q2 | -38.24 Million AUD | 0.0% |
| 2015 Q1 | -38.24 Million AUD | -253.69% |
| 2015 Q3 | -32.58 Million AUD | 14.8% |
| 2014 Q1 | -4.53 Million AUD | 38.01% |
| 2014 Q4 | -10.81 Million AUD | 0.0% |
| 2014 FY | -10.81 Million AUD | -47.79% |
| 2014 Q3 | -10.81 Million AUD | -138.41% |
| 2014 Q2 | -4.53 Million AUD | 0.0% |
| 2013 Q2 | -9.64 Million AUD | 0.0% |
| 2013 Q3 | -7.31 Million AUD | 24.18% |
| 2013 Q4 | -7.31 Million AUD | 0.0% |
| 2013 FY | -7.31 Million AUD | 49.7% |
| 2013 Q1 | -9.64 Million AUD | 33.66% |
| 2012 FY | -14.54 Million AUD | 18.88% |
| 2012 Q4 | -14.54 Million AUD | 0.0% |
| 2011 FY | -17.93 Million AUD | 4.57% |
| 2011 Q4 | -17.93 Million AUD | 0.0% |
| 2010 FY | -18.78 Million AUD | -183.24% |
| 2010 Q4 | -18.78 Million AUD | 0.0% |
| 2009 FY | -6.63 Million AUD | 21.23% |
| 2009 Q4 | -6.63 Million AUD | 0.0% |
| 2008 Q4 | -8.42 Million AUD | 0.0% |
| 2008 FY | -8.42 Million AUD | 45.64% |
| 2007 FY | -15.49 Million AUD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AVITA Medical, Inc. | -26.23 Million USD | 10.455% |
| Manhattan Scientifics, Inc. | -7000.00 USD | -335457.143% |
| Össur hf. | 395.08 Million USD | 105.945% |
| QHSLab, Inc. | 1.72 Million USD | 1457.769% |
| Wellstar International, Inc. | 51.36 Million USD | 145.728% |
| Össur hf. | 395.08 Million USD | 105.945% |
| CVR Medical Corp. | - USD | Infinity% |
| Bionovate Technologies Corp | - USD | Infinity% |
| Escalon Medical Corp. | 315.68 Thousand USD | 7540.621% |
| Aurora Spine Corporation | 1.9 Million USD | 1331.302% |
| BrainsWay Ltd. | -10.32 Million USD | -127.607% |
| Lattice Biologics Ltd. | - USD | Infinity% |
| BioElectronics Corporation | 14.82 Million USD | 258.425% |
| Hamilton Thorne Ltd. | 18.12 Million USD | 229.587% |
| Vivos Inc. | -1.59 Million USD | -1375.174% |
| Kelyniam Global, Inc. | 487.33 Thousand USD | 4919.908% |
| REMSleep Holdings, Inc. | -540.98 Thousand USD | -4241.887% |
| Zecotek Photonics Inc. | 2.76 Million USD | 950.296% |
| Avitar, Inc. | 5.17 Million USD | 554.231% |
| Nanomix Corporation | 11.38 Million USD | 306.24% |
| EKF Diagnostics Holdings plc | -4.61 Million USD | -408.731% |
| Theraclion SA | -5.86 Million EUR | -300.526% |
| Lifeline Biotechnologies, Inc. | - USD | Infinity% |
| Positron Corporation | 1.68 Million USD | 1492.452% |
| Rafina Innovations Inc. | - USD | Infinity% |
| Electromedical Technologies, Inc. | 1.61 Million USD | 1558.181% |
| Lombard Medical, Inc. | 11.49 Million USD | 304.341% |
| ALR Technologies Inc. | 19.14 Million USD | 222.669% |
| Stratec SE | 119.12 Million USD | 119.718% |
| Vycor Medical, Inc. | 1.05 Million USD | 2330.765% |
| Heart Tronics, Inc. | 54.99 Thousand USD | 42811.156% |
| MicroPort Scientific Corporation | 673.58 Million USD | 103.487% |
| VMS Rehab Systems, Inc. | 133.52 USD | 17592221.031% |
| NewCardio, Inc. | 2.41 Million USD | 1072.619% |
| Guided Therapeutics, Inc. | 1.46 Million USD | 1701.16% |
| Ingen Technologies, Inc. | 630.91 Thousand USD | 3822.982% |
| Odyssey Group International, Inc. | 2.1 Million USD | 1214.387% |
| CYduct Diagnostics, Inc. | 640.19 Thousand USD | 3769.027% |
| Wellness Center USA, Inc. | 3.98 Million USD | 689.364% |
| SANUWAVE Health, Inc. | 30.14 Million USD | 177.915% |
| IR-Med Inc. | -606 Thousand USD | -3776.073% |
| Perimeter Medical Imaging AI, Inc. | -13.78 Million USD | -70.367% |
| Polarean Imaging plc | -5.94 Million USD | -295.003% |
| United American Healthcare Corporation | -9.32 Million USD | -151.839% |
| ECGI Holdings, Inc. | 3.17 Million USD | 840.687% |
| Nu-Med Plus, Inc. | 93.19 Thousand USD | 25304.412% |
| Capital Group Holdings, Inc. | -3508.00 USD | -669483.808% |
| ADM Tronics Unlimited, Inc. | 262.61 Thousand USD | 9044.17% |
| Medical Supply International USA, Inc. | 216.6 Thousand USD | 10944.013% |
| Urologix, Inc. | 4.61 Million USD | 608.971% |
| Rapid Therapeutic Science Laboratories, Inc. | 4.2 Million USD | 658.01% |
| Nexeon MedSystems Inc. | 3.33 Million USD | 805.111% |
| SS Innovations International, Inc. | 1.18 Million USD | 2081.617% |
| Qualis Innovations, Inc. | 6671.00 USD | 352206.131% |
| Smith & Nephew plc | 2.77 Billion USD | 100.846% |
| NIOX Group Plc | -23.93 Million USD | 1.853% |
| Fuse Medical, Inc. | 1.75 Million USD | 1438.027% |
| Broncus Holding Corporation | -81.42 Million USD | 71.153% |
| Brain Scientific Inc. | 2.11 Million USD | 1210.186% |
| Pressure BioSciences, Inc. | 22.67 Million USD | 203.58% |
| Health Logic Interactive Inc. | 39.55 Thousand USD | 59480.135% |